Figure 1
From: Profiling placental DNA methylation associated with maternal SSRI treatment during pregnancy

Comparisons for analysis of differential DNAme associated with SSRI exposure and maternal depression in the discovery cohort. (A) The SSRI model investigates SSRI exposure in the full cohort (n = 64), comparing SSRI-exposed (n = 20) to SSRI non-exposed (n = 44) cases, adjusting for mean maternal Hamilton Depression score across gestation. (B) The SSRIs in maternal depression model investigates SSRI exposure in all maternally-depressed cases (mean maternal Hamilton Depression score > 8, n = 34), this model compares SSRI-exposed, maternally depressed cases (n = 14) to SSRI non-exposed, maternally depressed cases (n = 20). (C) The maternal depression without SSRIs model investigates the effect of maternal depression in cases not exposed to SSRIs (n = 44), this model compares SSRI non-exposed, maternally depressed cases (n = 20) to SSRI non-exposed and not maternally depressed cases (n = 24).